Specialty Drugs

Innovative new drugs hold great promise for patients with chronic conditions such as cancer, HIV, AIDS, and autoimmune diseases including rheumatoid arthritis. Often derived from living cells, these “specialty drugs” can save lives and alleviate suffering, but they frequently are costly. Prices can range from thousands to hundreds of thousands of dollars per patient per year. In fact, although fewer than 2 percent of all patients use such drugs, they are projected to account for more than half of all drug expenditures by 2020.

Our Work

Media Contact

Erin Davis

Officer, Communications